AB0147 The effect of treatment with hydroxychloroquine on soluble tissue factor levels in patients with antiphospholipid antibodies and antiphospholipid syndrome with and without underlying systemic lupus erythematosus

Abstract

BackgroundAntiphospholipid syndrome (APS) is characterized by venous, microvascular and/or arterial and/or obstetric morbidity (obstetric APS) in patients who are persistently positive for antiphospholipid antibodies (aPL)[1]. The mainstay of treatment is...